Phase 3 Clinical Trial Finds Drug, Baricitinib, of Benefit to Rheumatoid Arthritis Patients Who Failed at Other Treatments
News
Results from an international Phase 3 trial evaluating baricitinib as an rheumatoid arthritis (RA) treatment in patients who failed at other therapies reported a significant reduction in symptoms and ... Read more